Nine out of 10 Parkinson’s patients risk losing their voice, but a new United Kingdom study offers hope.
Researchers at the University of Birmingham found that an intensive voice treatment called Lee Silverman voice treatment (LSVT) LOUD outperformed standard therapy in maintaining speaking ability.
Challenge to Conventional Speech Therapy
The University of Birmingham conducted a trial from September 2016 to March 2020 that involved 388 Parkinson’s patients with dysarthria (difficulty speaking due to weak speech muscles).
George Citroner
Author
George Citroner reports on health and medicine, covering topics that include cancer, infectious diseases, and neurodegenerative conditions. He was awarded the Media Orthopaedic Reporting Excellence (MORE) award in 2020 for a story on osteoporosis risk in men.
